• Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Analysts

    来源: Buzz FX / 28 2月 2025 02:11:19   America/Chicago


    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Shares of Ultragenyx Pharmaceutical Inc.
    Read more...
分享